Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
Publication
, Journal Article
Piccini, JP; Kong, DF
Published in: Europace
March 2011
Duke Scholars
Published In
Europace
DOI
EISSN
1532-2092
Publication Date
March 2011
Volume
13
Issue
3
Start / End Page
295 / 296
Location
England
Related Subject Headings
- Treatment Outcome
- Sotalol
- Propafenone
- Humans
- Flecainide
- Evidence-Based Medicine
- Dronedarone
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anti-Arrhythmia Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., & Kong, D. F. (2011). Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement? Europace, 13(3), 295–296. https://doi.org/10.1093/europace/eur029
Piccini, Jonathan P., and David F. Kong. “Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?” Europace 13, no. 3 (March 2011): 295–96. https://doi.org/10.1093/europace/eur029.
Piccini JP, Kong DF. Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement? Europace. 2011 Mar;13(3):295–6.
Piccini, Jonathan P., and David F. Kong. “Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?” Europace, vol. 13, no. 3, Mar. 2011, pp. 295–96. Pubmed, doi:10.1093/europace/eur029.
Piccini JP, Kong DF. Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement? Europace. 2011 Mar;13(3):295–296.
Published In
Europace
DOI
EISSN
1532-2092
Publication Date
March 2011
Volume
13
Issue
3
Start / End Page
295 / 296
Location
England
Related Subject Headings
- Treatment Outcome
- Sotalol
- Propafenone
- Humans
- Flecainide
- Evidence-Based Medicine
- Dronedarone
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anti-Arrhythmia Agents